Accumulation of D-2-hydroxyglutaric
acid (D-2-HG) is the biochemical hallmark of
D-2-hydroxyglutaric aciduria type I and, particularly, of
D-2-hydroxyglutaric aciduria type II (D2HGA2). D2HGA2 is a metabolic inherited disease caused by gain-of-function mutations in the gene
isocitrate dehydrogenase 2. It is clinically characterized by neurological abnormalities and a severe
cardiomyopathy whose pathogenesis is still poorly established. The present work investigated the potential
cardiotoxicity D-2-HG, by studying its in vitro effects on a large spectrum of bioenergetics parameters in heart of young rats and in cultivated H9c2 cardiac myoblasts. D-2-HG impaired cellular respiration in purified mitochondrial preparations and crude homogenates from heart of young rats, as well as in
digitonin-permeabilized H9c2 cells.
ATP production and the activities of
cytochrome c oxidase (complex IV),
alpha-ketoglutarate dehydrogenase,
citrate synthase and
creatine kinase were also inhibited by D-2-HG, whereas the activities of complexes I, II and II-III of the respiratory chain,
glutamate,
succinate and
malate dehydrogenases were not altered. We also found that this organic
acid compromised mitochondrial Ca2+ retention capacity in heart mitochondrial preparations and H9c2 myoblasts. Finally, D-2-HG reduced the viability of H9c2 cardiac myoblasts, as determined by the MTT test and by
propidium iodide incorporation. Noteworthy, L-2-hydroxyglutaric
acid did not change some of these measurements (complex IV and
creatine kinase activities) in heart preparations, indicating a selective inhibitory effect of the enantiomer D. In conclusion, it is presumed that D-2-HG-disrupts mitochondrial bioenergetics and Ca2+ retention capacity, which may be involved in the
cardiomyopathy commonly observed in D2HGA2.